Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Oct 18 - Oct 23
However, tirzepatide can affect certain lab values like blood sugar, hemoglobin A1c, and liver enzymes, which is worth knowing if you have upcoming blood work
Several GLP-1 agonists have FDA approval for other indications that may overlap with BED patient populations: Semaglutide (Wegovy) and liraglutide (Saxenda) are approved for chronic weight management in adults with obesity (BMI 30) or overweight (BMI 27) with at least one weight-related comorbidity Semaglutide (Ozempic), liraglutide (Victoza), dulaglutide (Trulicity), and tirzepatide (Mounjaro) are approved for type 2 diabetes management Tirzepatide (Zepbound) is approved for chronic weight management When clinicians prescribe GLP-1 agonists for BED, this constitutes off-label use a legal and common practice in medicine when evidence suggests potential benefit and approved treatments are inadequate
CRISPR J
Gorgojo-Martinez et al
Beyond the numbers, the GIP component in Tirzepatide may lead to better tolerability
US$ 20.18
US$ 27.47
US$ 23.90
US$ 24.43
US$ 29.45
US$ 29.59
